Figure 1.
Patient and treatment characteristics. Pie charts depicting proportions of patients by (A) age category (with age measured in years at start of targeted therapy), (B) histiocytosis subtype, (C) inhibitor subtype (at start of targeted therapy), or (D) clinical trial enrollment.